Kessler, S. M., Lederer, E., Laggai, S., Golob-Schwarzl, N., Hosseini, K., Petzold, J., . . . Haybaeck, J. (2017). IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer. Oncotarget.
استشهاد بنمط شيكاغوKessler, Sonja M., et al. "IMP2/IGF2BP2 Expression, but Not IMP1 and IMP3, Predicts Poor Outcome in Patients and High Tumor Growth Rate in Xenograft Models of Gallbladder Cancer." Oncotarget 2017.
MLA استشهادKessler, Sonja M., et al. "IMP2/IGF2BP2 Expression, but Not IMP1 and IMP3, Predicts Poor Outcome in Patients and High Tumor Growth Rate in Xenograft Models of Gallbladder Cancer." Oncotarget 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.